EUVIMEDEUVIMED entdecken
Crossref

Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study

Thomas Le Tat, Robert Carlier, Norbert Zhang, Antoine Bouchet, Raphaël Amar, Jeffery Zhou, Mostafa El Hajjam

CardioVascular and Interventional Radiology · 2023

DOI: 10.1007/s00270-023-03488-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2023. Verfasst von Thomas Le Tat und 6 weiteren Autor:innen. Beteiligte Einrichtung: Imaging Department, Ambroise Paré Hospital (AP-HP), 9 Av. Charles de Gaulle, 92100, Boulogne-Billancourt, France. letat.thomas@yahoo.fr. Hauptthemen laut MEDLINE: Pancreatitis, Lung Neoplasms, Embolization, Therapeutic, Endovascular Procedures. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: The aim of this study was to evaluate the efficacy and safety of endovascular treatment of hemoptysis caused by primary lung cancer. METHODS: We conducted a single-center retrospective study (2005-2021), including patients who underwent thoracic embolization for life-threatening hemoptysis complication of lung cancer. Exclusion criteria were hemoptysis caused by a benign lung tumor or by a lung metastasis of a primary non-lung tumor. Depending on the origin of the bleeding, determined by CT-angiography, systemic arteries were treated with microspheres or coils, and pulmonary arteries with coils, plugs or covered stents. Outcomes were assessed from patients' medical records in April 2022. Primary endpoints were clinical success at one month and at one year. Secondary endpoints were incidence of complications, 1 year overall survival, and relative risk of recurrence of hemoptysis. Survival was compared with a log-rank test. RESULTS: Sixty-two patients underwent 68 systemic artery embolizations and 14 pulmonary artery procedures. Clinical success defined as cessation of hemoptysis without any recurrence was 81% at one month and 74% at one year. Three major complications occurred: spinal cord ischemia, stroke, and acute pancreatitis. 5% of patient died from hemoptysis. One-year overall survival was 29% and was significantly higher in patients without hemoptysis recurrence when compared to patients with recurring hemoptysis (p = 0.021). In univariate analysis, recurrence of hemoptysis at one year was associated with massive hemoptysis (RR = 2.50; p = 0.044) and with tumor cavitation (RR = 2.51; p = 0.033). CONCLUSION: Endovascular treatment for primary lung cancer-related hemoptysis is effective but not uneventful.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisLung NeoplasmsEmbolization, TherapeuticEndovascular ProceduresHumansHemoptysisRetrospective StudiesAcute DiseaseTreatment OutcomeNeoplasm Recurrence, LocalPulmonary ArteryBronchial Arteries

Stichwörter der Autor:innen

Bronchial arteryEmbolizationHemoptysisLung cancer

Autor:innen und Institutionen

  • Imaging Department, Ambroise Paré Hospital (AP-HP), 9 Av. Charles de Gaulle, 92100, Boulogne-Billancourt, France. letat.thomas@yahoo.fr.
  • Imaging Department, Ambroise Paré Hospital (AP-HP), 9 Av. Charles de Gaulle, 92100, Boulogne-Billancourt, France.

Zitieren

APA

Le Tat, T., Carlier, R., Zhang, N., Bouchet, A., Amar, R., Zhou, J., & El Hajjam, M. (2023). Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-023-03488-w

Vancouver

Le Tat T, Carlier R, Zhang N, Bouchet A, Amar R, Zhou J, et al. Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study. CardioVascular and Interventional Radiology. 2023. doi:10.1007/s00270-023-03488-w

BibTeX
@article{LeTat2023,
  author = {Le Tat, Thomas and Carlier, Robert and Zhang, Norbert and Bouchet, Antoine and Amar, Raphaël and Zhou, Jeffery and El Hajjam, Mostafa},
  title = {Endovascular Management of Life-Threatening Hemoptysis in Primary Lung Cancer: A Retrospective Study},
  journal = {CardioVascular and Interventional Radiology},
  year = {2023},
  doi = {10.1007/s00270-023-03488-w}
}
Kostenlos starten →